Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation

We're proud to support a new study with our partner McLean Hospital exploring how the expression of a gene may function as a switch to regulate feelings of fear in psychiatric illnesses such as Post-Traumatic Stress Disorder (PTSD).

Learn more about this study from McLean Hospital, and read the study published in Nature Communications.

Share this article:

More from CVB

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.